Related Experiment Video
Updated: Jun 16, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Fever of unknown origin: cost of illness study
Ivana Lesnjak1,2, Biljana Popovska Jovicic2,3, Katarina Jankovic1
1Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Objectives:
To analyze the structure of direct treatment costs for FUO and identify key cost-driving factors.
Methods:
A retrospective pharmacoeconomic analysis using a bottom-up approach was conducted on 71 patients treated for FUO at the Clinic for Infectious Diseases, University Clinical Centre Kragujevac, between 2016 and 2022. Treatment cost data were extracted from the electronic medical records.
Results:
The total direct cost was €81,655.20, with a mean of €1,150.07 ± 3,434.60 per patient with a median of €549.55 (IQR=€512.62). Major cost components included pharmacotherapy (49.40 %; €40,337.26), diagnostic procedures (30.52 %; €24,923.44), and hospitalisation (10.32 %; €8,324.00). Significant cost determinants were the following: gender, the Charlson comorbidity index, hospital stay duration, number of medications administered per patient, and number of specialist consultations.
Conclusions:
Pharmacotherapy, especially broad-spectrum antibiotics and antifungals, along with diagnostics and hospitalisation, are the main contributors to FUO treatment costs. Patient-specific factors, particularly comorbidities and service utilisation, play a significant role in determining overall healthcare expenditure.
Related Concept Videos
Types of Fever
Here are the different types of fever:
Investigation of Disease Outbreaks
Patterns of Fever
Factors Affecting Illness
For instance, risk factors are connected to illness, disability,...
Increased Body Temperature
Methods of reducing fever
Pharmacological Methods of Reducing Fever: